Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Hepatitis01:25

Hepatitis

86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same author

Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacy.

JHEP reports : innovation in hepatology·2026
Same author

Helminth infection modulates the immunogenicity of COVID-19 vaccines in mice without compromising protective efficacy.

Frontiers in immunology·2026
Same author

Correction: Maurer et al. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. <i>J. Fungi</i> 2022, <i>8</i>, 1265.

Journal of fungi (Basel, Switzerland)·2026
Same author

Comparative genomics identifies small interfering RNA with activity against all five human betacoronaviruses.

Genome medicine·2026
Same author

The composition of MDSC-subpopulations PMN-like, M-like, and e-like MDSC is associated with the severity of infectious mononucleosis in pediatric patients.

Frontiers in immunology·2026

Related Experiment Video

Updated: May 5, 2026

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
08:30

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

9.0K

Hepatitis B Virus Neutralization with DNA Origami Nanoshells.

Elena M Willner1, Fenna Kolbe2, Frank Momburg3

  • 1Department of Biosciences, School of Natural Sciences and Munich Institute of Biomedical Engineering, Technical University of Munich, Boltzmannstraße 11, 85748 Garching, Germany.

ACS Applied Materials & Interfaces
|May 10, 2024
PubMed
Summary

DNA origami nanoshells trap and neutralize hepatitis B virus (HBV) effectively. This novel antiviral strategy enhances antibody potency by 100-fold, offering a promising new approach for combating viral infections.

Keywords:
DNA origamiantiviralshepatitis B virusin vitro neutralizationviral blocking

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.3K

Related Experiment Videos

Last Updated: May 5, 2026

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
08:30

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

9.0K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.3K

Area of Science:

  • Nanotechnology
  • Virology
  • Biochemistry

Background:

  • Hepatitis B virus (HBV) poses a significant global health challenge.
  • Current antiviral therapies have limitations in efficacy and resistance.
  • Developing novel strategies for virus neutralization is crucial.

Purpose of the Study:

  • To demonstrate the use of DNA origami nanoshells for virus trapping.
  • To evaluate the neutralization efficiency of these nanoshells against HBV.
  • To investigate the mechanisms behind enhanced antiviral activity.

Main Methods:

  • Fabrication of virus-trapping nanoshells using DNA origami.
  • Modification of nanoshells with synthetic monoclonal antibodies targeting the HBV envelope.
  • Assessment of HBV neutralization in cell culture models.

Main Results:

  • DNA origami nanoshells efficiently trapped and neutralized HBV in cell culture.
  • Antibody-modified nanoshells exhibited approximately 100-fold increased neutralization potency compared to free antibodies.
  • Nanoshells acted as a physical barrier and enhanced virus binding through avidity.

Conclusions:

  • DNA origami-based nanoshells represent a potent antiviral platform.
  • This system significantly enhances the effectiveness of antibodies for virus neutralization.
  • The study highlights the potential for rationally designing antivirals using DNA nanotechnology.